Cargando…

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients

The prognosis of patients with advanced pancreatic cancer is extremely poor and there are only a few standard treatments. Here, we report the results of a Phase I clinical trial to investigate the safety, immunostimulatory effects, and antineoplastic activity of a multi-target vaccine composed of fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuyama, Ryuji, Aruga, Atsushi, Hatori, Takashi, Takeda, Kazuyoshi, Yamamoto, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906430/
https://www.ncbi.nlm.nih.gov/pubmed/24498547
http://dx.doi.org/10.4161/onci.27010